KNSA
Kiniksa InternationalFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
9
U.S. public peers
Grade Position
Below peers
vs peer average
KNSA vs peer average
29/100
KNSA vs. peer average (F vs. D)
Grade spread
A 1 · B 1 · C 1 · D 3 · F 3
Graded peers loaded
Coverage
9 graded
100% of tracked
Peer overview
BMRN is the first available peer comparator.
Established rare-disease biotech with commercial products and experience navigating regulatory/reimbursement hurdles; relevant for pricing and lifecycle dynamics.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
KNSA
Kiniksa International
BMRN
BioMarin Pharmaceutical
Grade
F
A
Momentum
82
57
Value
60
64
Sentiment
0
73
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive
Grade position vs BMRN
KNSA / BMRN
Grade Position
Below peers
KNSA vs. peer average (F vs. D)
29/100
Momentum
82
KNSAValue
60
BMRNSentiment
0
BMRNRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs KNSA
BMRN is the first peer returned for this comparison set.